PLG and cancer: On the surface of cancer cells, ENO1 acts as a plasminogen receptor, promoting the degradation of plasminogen to plasmin, a serine protease involved in the degradation of extracellular matrix, thus facilitating the invasion and metastasis of the cell [37].